Results 61 to 70 of about 314 (129)

Disseminated cryptococcosis in an HIV-negative patient [PDF]

open access: yesInternational Journal of Infectious Diseases, 2009
n ...
Stefano Licci, Pasquale Narciso
openaire   +3 more sources

A Global Health Alert on the Re‐Emergence of Mpox a Viral Zoonotic Illness Its Prevention and Management: A Narrative Review

open access: yesHealth Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims Monkeypox virus (MPXV) is gaining attention in the global health community due to its potential for human transmission and similarities to the well‐known smallpox virus. Mpox was first detected in the 1970s and mostly affects Central and West Africa.
Muslim Bin Aqeel   +5 more
wiley   +1 more source

Oral Cryptococcosis due to Naganishia diffluens in a Patient With Thalassemia: A Case Report and a Literature Review

open access: yesJournal of Clinical Laboratory Analysis, Volume 40, Issue 11, June 2026.
Naganishia diffluens, a rare non‐neoformans cryptococcal species, was identified by PCR sequencing as the causative agent of oral cryptococcosis in a 31‐year‐old Iranian man with β‐thalassemia. This case represents the first documented instance of oral infection by N.
Zahra Yahyazadeh   +13 more
wiley   +1 more source

Pulmonary cryptococcosis with cryptococcal meningitis in an immunocompetent host

open access: yesLung India, 2014
Cryptococcosis is a systemic fungal infection associated with significant morbidity and mortality. It predominantly affects people with immunosuppresion and human immunodeficiency virus infection.
Manoj Kumar Panigrahi   +3 more
doaj   +1 more source

Lung Microbiome Diversity, Infection Dynamics, and Microbe‐Mediated Cross‐Protection

open access: yesMicrobiologyOpen, Volume 15, Issue 3, June 2026.
The protective role of the lung microbiome in maintaining respiratory health by promoting immune homeostasis, pathogen exclusion, and barrier integrity. Diverse microbial communities regulate immune maturation, enhance epithelial defenses, and contribute to antiviral responses, collectively preventing pathogen colonization and sustaining a balanced ...
Sana Arooj   +7 more
wiley   +1 more source

An exceptional case report of disseminated cryptococcosis in a hitherto immunocompetent patient

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 2020
Cryptococcosis is an opportunistic fungal infection causes significant disease predominantly in immunocompromised patients. Here we present an excepcional case of disseminated cryptococcosis with pulmonary and cerebral involvement in an immunocompetent ...
Tatjana Adzic-Vukicevic   +6 more
doaj   +1 more source

Disseminated Cryptococcosis in a Young Immunocompetent Male

open access: yesIndian Journal of Hematology and Blood Transfusion, 2020
Cryptococcosis is an opportunistic infection caused by encapsulated yeasts of genus Cryptococcus. It usually infects immunocompromised patients and has multisystemic involvement, the common sites being lungs, central nervous system, skin and bone marrow. Disseminated cryptococcosis has also been reported in immunocompetent individuals.
Saurabh, Donald   +2 more
openaire   +3 more sources

Video‐Based Training on Physicians' Proficiency in Invasive Fungal Disease: A Multicentre, Cluster Randomised Controlled Trial

open access: yesMycoses, Volume 69, Issue 6, June 2026.
ABSTRACT Background Previous research indicated that physicians possess limited knowledge of the diagnosis and treatment of invasive fungal disease (IFD). Objective This study aimed to assess the efficacy of training via video or PDF formats in increasing physicians' knowledge of IFD.
Yijian Chen   +18 more
wiley   +1 more source

Disseminated cryptococcosis in Crohn’s disease: a case report

open access: yesBMC Infectious Diseases, 2018
Background Gastrointestinal (GI) cryptococcosis is rarely reported. Most cases were diagnosed during evaluation of comorbid conditions, incidental findings, or postmortem.
Natthakit Chavapradit   +1 more
doaj   +1 more source

Pulmonary Cryptococcal Infection Complicating Gefitinib Therapy in a Patient With EGFR L858R‐Positive Lung Adenocarcinoma: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT In patients with EGFR‐mutant lung adenocarcinoma receiving gefitinib or other EGFR‐TKIs, the development of new pulmonary nodules should not be hastily attributed to disease progression; secondary pulmonary cryptococcosis should be considered in the differential diagnosis.
Yun Wang   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy